X hits on this document

Word document

The usefulness and use of second-generation - page 79 / 81

225 views

0 shares

0 downloads

0 comments

79 / 81

APPENDIX 7:  Resolution adopted by the General Assembly of the World Psychiatric Association on 26 August 2002 in Yokohama, Japan, and containing the Consensus Statement on

THE USEFULNESS AND USE OF SECOND-GENERATION

ANTI-PSYCHOTIC MEDICATIONS

The General Assembly of the World Psychiatric Association,

Having considered the evidence on the effectiveness, side-effects, use and usefulness of the second generation antipsychotic medications presented to it by the WPA Task Force that assembled the relevant material in the Technical Review of such evidence and in its Update;

Having taken note of the fact that the Technical Review of the evidence has been presented to all of its Member Societies and that discussions of this document have been organized by more than twenty of its Member Societies and involved, not only psychiatrists but also other relevant specialists, and representatives of governments and patient and family organizations;

Recognizing that these meetings and the correspondence with Member Societies have made it possible to take into account the experience obtained in using these medications in many countries as well as the relevant evidence in preparing the Technical Reviews submitted to the WPA;

Aware of its constitutional mandate to do all that is within its power to improve the care for people with mental disorders;

(1)Expresses its satisfaction with the intensive process of consultation used in the preparation of the relevant documents and commends the Executive

Committee of the WPA for its leadership and the WPA Task Force for its

efforts in developing  the relevant documentation, coordinating national and international consultations and presenting  the materials for discussion during WPA official meetings;

(2)Thanks the Member Societies, individual experts, professional associations

and governmental and nongovernmental organizations for the contributions

they have made in the process of reviewing the evidence and experience with

this group of medications;

(3)Thanks academic institutions for their support and the pharmaceutical companies for the unrestricted educational grants that have greatly facilitated the work on this matter;

Document info
Document views225
Page views225
Page last viewedFri Dec 09 03:14:51 UTC 2016
Pages81
Paragraphs1517
Words24865

Comments